![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Forest Labs Delays Lung Disease Drug Filing
Forest Labs Delays Lung Disease Drug Filing
August 15, 2013
Forest Laboratories and Almirall announced that they are delaying filing for FDA approval for their combination Tudorza and formoterol drug for chronic obstructive pulmonary disease. The delay, the companies said, is due to issues in chemistry, manufacturing and controls.
Bloomberg Business Week
Bloomberg Business Week
Upcoming Events
-
21Oct